Corbus Pharma (CRBP) Misses Q2 EPS by 55c

Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($1.81), $0.55 worse than the analyst estimate of ($1.26).

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Fold Holdings (FLD) files for 51.23M share offering by selling stockholders
• Anthropic expects over $100B in annualized revenue this year - Bloomberg